Gemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter study
dc.contributor.author | İnal, Ali | |
dc.contributor.author | Işıkdoğan, Abdurrahman | |
dc.contributor.author | Koş, F. Tuğba | |
dc.contributor.author | Algın, Efnan | |
dc.contributor.author | Gümüş, Mahmut | |
dc.contributor.author | Dikilitaş, Mustafa | |
dc.contributor.author | Elkıran, Emin Tamer | |
dc.date.accessioned | 2020-03-26T18:14:45Z | |
dc.date.available | 2020-03-26T18:14:45Z | |
dc.date.issued | 2011 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description.abstract | [Abstract not Available] | en_US |
dc.identifier.doi | 10.1200/jco.2011.29.15_suppl.e14534 | en_US |
dc.identifier.issn | 0732-183X | en_US |
dc.identifier.issn | 1527-7755 | en_US |
dc.identifier.issue | 15 | en_US |
dc.identifier.uri | https://dx.doi.org/10.1200/jco.2011.29.15_suppl.e14534 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/26516 | |
dc.identifier.volume | 29 | en_US |
dc.identifier.wos | WOS:000208880303588 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | AMER SOC CLINICAL ONCOLOGY | en_US |
dc.relation.ispartof | JOURNAL OF CLINICAL ONCOLOGY | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.title | Gemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter study | en_US |
dc.type | Conference Object | en_US |